Adaliz Santaliz-Cruz

FDA investigator

Appears on 6 documents from 2012 to 2022, mostly at sites in Puerto Rico. Most often cites corrective and preventive action (21 CFR 820.100(a)).

6
Documents on file
6.2
Observations per 483
2012
First seen
2022
Most recent

What they cite most

From 37 observations

Activity by year

2012: 1, 2015: 2, 2019: 1, 2021: 1, 2022: 1

Where

Puerto Rico 4 · Maryland 1 · North Carolina 1

Is Adaliz Santaliz-Cruz coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Safeguard US Operating LLCMar 25, 2022 · Harrisburg, North Carolina
483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability CompanyJul 12, 2021 · Manati, Puerto Rico
483 Amgen Manufacturing Limited LLCApr 11, 2019 · Juncos, Puerto Rico
483 Zimmer Manufacturing B.VNov 17, 2015 · Mercedita, Puerto Rico
483 Edwards Lifesciences Technology SARLJan 27, 2015 · Anasco, Puerto Rico
483 St. Jude Medical Puerto Rico LLCOct 2, 2012 · Arecibo, Maryland

About this profile

What does Adaliz Santaliz-Cruz inspect?

Adaliz Santaliz-Cruz appears on 6 documents on file covering 6 sites, mostly in Puerto Rico.

What do they cite most often?

21 CFR 820.100(a) (corrective and preventive action), followed by 21 CFR 820.70 and 21 CFR 820.75.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Adaliz Santaliz-Cruz is dated Mar 25, 2022.